GW26-e4553 Analysis of risk factors for revascularization after percutaneous coronary invention of acute coronary syndrome  by Cao, Zhongying & Liu, Jun
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5 C173prevent the plaque shift!Compared with wire only or balloon without
opening, the technique offers considerable promise for the prevention
of severe stenosis or occlusion in the ostium of the side branch and
reduces the possibility of the implementation of the main branch-side
branch kissing balloon or the stent-angioplasty in the side branch.
CONCLUSIONS As a result, the operation time and X-ray exposure
time are both shortened and the contrast agent dosage is decreased.
More importantly, it does not increase difﬁculty for the procedure.
This is why we choose the technique, which is effective, safe and
simple to handle.GW26-e3963
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OBJECTIVES An accumulating body of evidence indicates that slow
coronary ﬂow (SCF) phenomenon seems to be an early-form of
atherosclerosis and low-grade inﬂammation plays a major role in the
atherosclerotic vascular processes. Interleukin (IL)-10 is a multifunc-
tional anti-inﬂammatory cytokine involved in various physiological
and pathophysiological processes including cardiovascular disease.
The aim of the present study is to investigate the association of IL-10
gene promotor -592A/C polymorphism with SCF in Han Chinese.
METHODS 250 patients who underwent coronary angiography and
had angiographically normal coronary arteries of varying coronary
ﬂow rates without any atherosclerotic lesion were enrolled in this
study. Patients who had thrombolysis in myocardial infarction frame
counts (TFC) above the normal cutoffs were considered to have SCF
and those within normal limits were considered to have normal cor-
onary ﬂow (NCF). The PCR-based restriction fragment length poly-
morphism (PCR-RFLP) technique was used to assess the genotypes
frequencies.
RESULTS There were 41 patients in the SCF group and 209 patients in
the NCF group. The distribution of the IL-10 -592A/C genotypes (AA,
AC, and CC) was 46.34%, 41.46%, and 12.20% in the NCF group, and
66.51%, 28.71%, and 4.78% in SCF subjects, respectively (p ¼ 0.0280).
The frequency of the A allele in the SCF group was signiﬁcantly higher
than that in the NCF group (80.86% vs 67.07%, p ¼0.0054). Compared
with the CC genotype, the AA genotype had increased risk of SCF in
both unadjusted (OR¼3.6579, 95%CI¼1.1288-11.8533, p¼0.0386) and
adjusted analyses (OR¼2.9967, 95%CI¼1.0929-8.2173, p¼ 0.0357). In
SCF patients, the average serum IL-10 levels in AA genotype
(1.780.17 ng/L) were statistically lower than in ACþCC genotype
(2.100.20 ng/L) (p<0.001).
CONCLUSIONS These ﬁndings suggest that IL-10 -592A/C poly-
morphism is associated with SCF and the A allele has increased risk for
SCF in Han Chinese.GW26-e4553
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OBJECTIVES percutaneous coronary invention (PCI) has been widely
used in the therapy of coronary heart disease (CHD) and obviously
improves the outcome of acute coronary syndrome (ACS) patients.
However, there are still many patients get clinical symptoms of CHD
after successful PCI, then they have to receive second revasculariza-
tion. The purpose of this retrospective study is to investigate the risk
factors of revascularization.
METHODS 510 patients undergoing CAG in the ﬁrst afﬁliated hospital
of Dalian medical university from 2010. 1 to 2014. 8 are accepted. 409
patients of them are received revascularization and we save the
clinical material of the ﬁrst and second PCI for the patients who
received several times of PCI. 101 patients are received coronary
angiography (CAG) that shows no coronary lesions and restenosis. We
estimate the baseline characteristics (age, sex, etal), cardiovascular
risk factor (hypertension, DM, etal), blood test indicators, ultrasonic
cardiogram of two groups. Then we divided patients received revas-
cularization into target lesion group (TLR), target vessel group (TVR),
non-target vessel group (NTVR), mixed lesion group (MLR) accordingto the way of revascularization. Continuous variables in subgroups are
analyzed by Student t test, variance analysis is used in multiple group
comparison, categorical variables are analyzed by Chi square test,
logistic analysis is used to analyze multivariate analysis. The P<0.05
is signiﬁcant in statistics.
RESULTS In revascularization group, mean age is 59.7510.34, male
328 (80.2%), and in control group, mean age is 60.2010.18, male 81
(80.2%). Referred to ﬁrst PCI, direct PCI patients (12.2% VS 2.9%, P ¼
0.029) and DM% (37.7% VS 27.7%, P ¼ 0.039) of revascularization
group are higher statistically, and age, sex, smoking, smoking index,
HP%, TC, TG, HDL, LDL, LPa, apolipoprotein A, apolipoprotein B,
cardiac function (EF, LVDD), CAG result are all statistically insigniﬁ-
cant between two groups. In the second PCI, LPa (271.74247.75 mg/l
VS 213.59192.09 mg/l, P ¼ 0.040), LDL-C (95.9729.84 mg/dl VS
87.3026.78 mg/dl, P ¼ 0.011) are higher and EF (54.987.79% VS
56.626.13%, P ¼ 0.040), the substandard LDL-C (100 mg/dl) %
(61.7% VS 71.7%, P ¼ 0.044) is lower in revascularization group. The
interval from ﬁrst PCI to second CAG, substandard TC (160 mg/dl)
are the independent risk factors for revascularization after PCI. In the
subgroups, patients of TVR are signiﬁcantly older than other groups,
substandard LDL% and LPa of NTVR and MLR are signiﬁcant higher
than controls.
CONCLUSIONS (1) This study indicates that DM, longer interval from
ﬁrst PCI to second CAG, substandard LDL and higher LPa may aggra-
vate the coronary lesions. (2) substandard TC after ﬁrst PCI and the
interval from ﬁrst PCI to second CAG are independent risk factors of
revascularization. (3) It’s necessary to control cardiovascular risk
factors after PCI, especially DM and lipidemia so to avoid re-
vascularization.GW26-e0702
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OBJECTIVES The aim of this study was to conduct a meta-analysis
comparing the occurrence of myocardial infarction of double drug-
eluting stent (DDS) versus single drug-eluting stent (SDS) in patients
with coronary bifurcations.
METHODS 5 randomized, controlled trials, for a total of 1,813 patients,
comparing DDS versus SDS for the treatment of patients with coronary
bifurcations were included. The primary outcome was the occurrence
of myocardial infarction. The secondary outcome measures were
drug-eluting stent (DES) thrombosis, target vessel revascularization
(TVR) and overall mortality. The risk ratios (RRs) with 95% conﬁdence
intervals (CL) was the effect measure.
RESULTS The occurrence of MI was signiﬁcantly increased with DDS
compared with SDS (RR: 1.88; 95% CI: 1.35 to 2.62). There were no
signiﬁcant differences in DES thrombosis (RR: 2.01; 95% CI: 0.77 to
5.23), TVR (RR: 0.80; 95% CI: 0.55 to 1.17) and Overall mortality (RR:
0.66; 95% CI: 0.25 to 1.72) with DDS compared with SDS.
CONCLUSIONS For coronary bifurcations, treatment with DDS
showed a trend of more development of MI than did treatment with
SDS.
GW26-e1433
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OBJECTIVES To evaluate the safety and efﬁcacy of 135 cm Corsair
microcatheter for complex coronary lesion in Percutaneous Coronary
Intervention (PCI).
METHODS 65 patients with complex coronary lesions such as
chronic total occlusion (CTO), bifurcation lesions, severely calciﬁed
lesions, and seriously tortuosity of the coronary artery, which
treated with 135cm Corsair microcatheter (Asahi Intec Co, Japan),
was enrolled retrospectively in this study from January 2011 to
December 2014. The success rate of PCI was analyzed. Unique
complications related to the Corsair microcatheter during operation
